Non-bacterial thrombotic endocarditis risk factors: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
 
(2 intermediate revisions by the same user not shown)
Line 7: Line 7:


==Risk Factors==
==Risk Factors==
The most potent risk factor in the development of non-bacterial thrombotic endocarditis is advanced malignancy<ref name="pmid4682494">{{cite journal |vauthors=Rosen P, Armstrong D |title=Nonbacterial thrombotic endocarditis in patients with malignant neoplastic diseases |journal=Am. J. Med. |volume=54 |issue=1 |pages=23–9 |date=January 1973 |pmid=4682494 |doi=10.1016/0002-9343(73)90079-x |url=}}</ref><ref name="pmid4682494">{{cite journal |vauthors=Rosen P, Armstrong D |title=Nonbacterial thrombotic endocarditis in patients with malignant neoplastic diseases |journal=Am. J. Med. |volume=54 |issue=1 |pages=23–9 |date=January 1973 |pmid=4682494 |doi=10.1016/0002-9343(73)90079-x |url=}}</ref>. Other risk factors include systemic lupus erythematosus, antiphospholipid syndrome <ref>Roldan CA, Qualls CR, Sopko KS, Sibbitt WL Jr. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: A randomized controlled study. The Journal of Rheumatology. 2008;35:224</ref>, and chronic inflammatory states.
The most potent risk factor in the development of non-bacterial thrombotic endocarditis is advanced malignancy<ref name="pmid1851590">{{cite journal |vauthors=González Quintela A, Candela MJ, Vidal C, Román J, Aramburo P |title=Non-bacterial thrombotic endocarditis in cancer patients |journal=Acta Cardiol |volume=46 |issue=1 |pages=1–9 |date=1991 |pmid=1851590 |doi= |url=}}</ref><ref name="pmid4682494">{{cite journal |vauthors=Rosen P, Armstrong D |title=Nonbacterial thrombotic endocarditis in patients with malignant neoplastic diseases |journal=Am. J. Med. |volume=54 |issue=1 |pages=23–9 |date=January 1973 |pmid=4682494 |doi=10.1016/0002-9343(73)90079-x |url=}}</ref>. Other risk factors include systemic lupus erythematosus, antiphospholipid syndrome <ref>Roldan CA, Qualls CR, Sopko KS, Sibbitt WL Jr. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: A randomized controlled study. The Journal of Rheumatology. 2008;35:224</ref>, and chronic inflammatory states.
 
{| class="wikitable"
|+Risk factors for the development of Non-bacterial endocarditis<ref name="urlNon-bacterial Thrombotic Endocarditis | IntechOpen">{{cite web |url=https://www.intechopen.com/books/infective-endocarditis/non-bacterial-thrombotic-endocarditis |title=Non-bacterial Thrombotic Endocarditis &#124; IntechOpen |format= |work= |accessdate=}}</ref>
!style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Risk factor}}
!style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Details}}
|-
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Advanced [[Stages of human development|stage]] [[malignancy]]
|Advanced [[Stages of human development|stage]] [[malignancies]] such as:
 
*Mucin-secreting and pancreatic adenocarcinoma<ref name="pmid17522239">{{cite journal |vauthors=el-Shami K, Griffiths E, Streiff M |title=Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment |journal=Oncologist |volume=12 |issue=5 |pages=518–23 |date=May 2007 |pmid=17522239 |doi=10.1634/theoncologist.12-5-518 |url=}}</ref>
*Adenocarcinoma of the lung
*Adenocarcinoma of the ovary
*Colon carcinoma
*Cancer of the prostate
*Cholangiocarcinoma
*Lymphoma
|-
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Systemic autoimmune diseases
|
*Systemic lupus erythematosus<ref name="pmid8875919">{{cite journal |vauthors=Roldan CA, Shively BK, Crawford MH |title=An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus |journal=N. Engl. J. Med. |volume=335 |issue=19 |pages=1424–30 |date=November 1996 |pmid=8875919 |doi=10.1056/NEJM199611073351903 |url=}}</ref>
*Antiphospholipid syndrome<ref name="pmid18085739">{{cite journal |vauthors=Roldan CA, Qualls CR, Sopko KS, Sibbitt WL |title=Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study |journal=J. Rheumatol. |volume=35 |issue=2 |pages=224–9 |date=February 2008 |pmid=18085739 |doi= |url=}}</ref>
*Systemic vasculitis i.e;
**Giant cell arteritis
**Takayasu's arteritis
**Polyangitis with granulomatosis
|-
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Hypercoagulable states
|
*Disseminated intravascular coagulation.
*Protein C and S deficiency
*Thrombotic micrangiopathy
|-
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Chronic inflammatory state
|
*Tuberculosis
*Uncontrolled HIV
*Chronic pyelonephritis
|-
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Others
|
*Adenomyosis
*Heart failure with valvulopathy
*Chronic renal disease
*Chronic alcoholism
|}


==References==
==References==

Latest revision as of 07:14, 7 August 2020

non-bacterial thrombotic endocarditis

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating non-bacterial thrombotic endocarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non-bacterial thrombotic endocarditis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-bacterial thrombotic endocarditis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-bacterial thrombotic endocarditis risk factors

CDC on Non-bacterial thrombotic endocarditis risk factors

Non-bacterial thrombotic endocarditis risk factors in the news

Blogs on Non-bacterial thrombotic endocarditis risk factors

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Non-bacterial thrombotic endocarditis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]

Overview

The most potent risk factor in the development of non-bacterial thrombotic endocarditis is advanced malignancy. Other risk factors include systemic lupus erythematosus, antiphospholipid syndrome, and chronic inflammatory states.

Risk Factors

The most potent risk factor in the development of non-bacterial thrombotic endocarditis is advanced malignancy[1][2]. Other risk factors include systemic lupus erythematosus, antiphospholipid syndrome [3], and chronic inflammatory states.

Risk factors for the development of Non-bacterial endocarditis[4]
Risk factor Details
Advanced stage malignancy Advanced stage malignancies such as:
  • Mucin-secreting and pancreatic adenocarcinoma[5]
  • Adenocarcinoma of the lung
  • Adenocarcinoma of the ovary
  • Colon carcinoma
  • Cancer of the prostate
  • Cholangiocarcinoma
  • Lymphoma
Systemic autoimmune diseases
  • Systemic lupus erythematosus[6]
  • Antiphospholipid syndrome[7]
  • Systemic vasculitis i.e;
    • Giant cell arteritis
    • Takayasu's arteritis
    • Polyangitis with granulomatosis
Hypercoagulable states
  • Disseminated intravascular coagulation.
  • Protein C and S deficiency
  • Thrombotic micrangiopathy
Chronic inflammatory state
  • Tuberculosis
  • Uncontrolled HIV
  • Chronic pyelonephritis
Others
  • Adenomyosis
  • Heart failure with valvulopathy
  • Chronic renal disease
  • Chronic alcoholism

References

  1. ↑ González Quintela A, Candela MJ, Vidal C, Román J, Aramburo P (1991). "Non-bacterial thrombotic endocarditis in cancer patients". Acta Cardiol. 46 (1): 1–9. PMID 1851590.
  2. ↑ Rosen P, Armstrong D (January 1973). "Nonbacterial thrombotic endocarditis in patients with malignant neoplastic diseases". Am. J. Med. 54 (1): 23–9. doi:10.1016/0002-9343(73)90079-x. PMID 4682494.
  3. ↑ Roldan CA, Qualls CR, Sopko KS, Sibbitt WL Jr. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: A randomized controlled study. The Journal of Rheumatology. 2008;35:224
  4. ↑ "Non-bacterial Thrombotic Endocarditis | IntechOpen".
  5. ↑ el-Shami K, Griffiths E, Streiff M (May 2007). "Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment". Oncologist. 12 (5): 518–23. doi:10.1634/theoncologist.12-5-518. PMID 17522239.
  6. ↑ Roldan CA, Shively BK, Crawford MH (November 1996). "An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus". N. Engl. J. Med. 335 (19): 1424–30. doi:10.1056/NEJM199611073351903. PMID 8875919.
  7. ↑ Roldan CA, Qualls CR, Sopko KS, Sibbitt WL (February 2008). "Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study". J. Rheumatol. 35 (2): 224–9. PMID 18085739.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Non-bacterial_thrombotic_endocarditis_risk_factors&oldid=1648343"